• <bdo id="6wc6y"></bdo>
  • <samp id="6wc6y"><option id="6wc6y"></option></samp>

    Recombinant Human sRANK Ligand/RANKL

    產品編號 規格 價格 貨期
    UBE-048 50ug ¥1280 現貨
    • 產品描述
    • 技術特性
    • 訂貨信息
    • 資料下載

    (1)50ug -----1280元



          RANKL and RANK are members of the TNF superfamily of ligands and receptors that play an important role in the regulation of specific immunity and bone turnover. RANK (receptor) was originally identified as a dendritic cell-membrane protein, which, by interacting with RANKL, augments the ability of dendritic cells. These dendritic cells then stimulate naïve T-cell proliferation in a mixed lymphocyte reaction, promote the survival of RANK+ T-cells, and regulate T-cell-dependent immune response. RANKL, which is expressed in a variety of cells, including osteoblasts, fibroblasts, activated T-cells and bone marrow stromal cells, is also capable of interacting with a decoy receptor called OPG. Binding of soluble OPG to sRANKL inhibits osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, thereby leading to excess accumulation of bone and cartilage. Human RANKL is reactive on murine cells. Recombinant Human sRANKL is a 20.0 kDa polypeptide comprising the TNF-homologous region of RANKL (176 amino acid residues).

           SDS-PAGE                                   Activity

  • <bdo id="6wc6y"></bdo>
  • <samp id="6wc6y"><option id="6wc6y"></option></samp>